deltatrials

Samuel Lunenfeld Research Institute, Mount Sinai Hospital Clinical Trials

Sponsors / Samuel Lunenfeld Research Institute, Mount Sinai Hospital

Samuel Lunenfeld Research Institute, Mount Sinai Hospital appears as lead sponsor on 123 trial records in ClinicalTrials.gov. Of these, 14 are recruiting, 1 are active without new recruitment, and 95 have completed. The registry records 8 terminated or withdrawn trials for Samuel Lunenfeld Research Institute, Mount Sinai Hospital. The most common reasons cited for termination include efficacy or futility findings, slow or insufficient recruitment. Planned participant enrollment across these trials sums to 9,307. Figures on this page are sourced from ClinicalTrials.gov and refreshed with each registry update.

123
Total Trials
14
Recruiting
1
Other Active
95
Completed
8
Terminated / Withdrawn
9,307
Total Enrollment

Termination reasons: Other50% · Efficacy25% · Recruitment25%

Recent Terminations

  • NCT02762669 Phase NA Stopped Dec 2023
    Postpartum Hemorrhage
  • NCT03593980 Phase NA Stopped Jun 2020
    Pregnancy
    "Study could not be run for logistical reasons"
  • NCT02762149 Phase NA Stopped Aug 2016
    Labor Pain
    "Analysis after 20 patients was convincing for a negative result for the primary outcome, so the study was stopped."
  • NCT01563939 Phase NA Stopped Dec 2014
    Pain
    "Difficult recruitment."
  • NCT01563835 Phase NA Stopped Jan 2014
    Pain
    "Recruitment difficulty"
  • NCT00777387 Phase NA Stopped Jan 2014
    Infertility
    "Studies emerged that demonstrated the superiority of vitrification"
  • NCT01383122 Phase NA Stopped Mar 2012
    Pain
    "Planned interim analysis-no statistical significance for the primary outcome."
  • NCT00573664 Phase NA Stopped Feb 2009
    Pain
    "Interim analysis showed a significant reduction in the pain scores"

Active Trials (1 total)

Top Conditions

Top Locations